Monday, February 15, 2010

Migraine Drugs Pose No Increased Risk of Birth Defects


New to Somebody Heal Me? Subscribe to the Somebody Heal Me feed:
Subscribe in a reader or subscribe by e-mail. Follow me on Twitter @somebodyhealme.

A study of 70,000 pregnant women seems to demonstrate there is no increased risk of birth defects among children born to women who use triptans for migraine treatment during pregnancy. The triptan category includes the drugs Imitrex, Maxalt, Zomig, Relpax and Axert.

Migraine Drugs Don't Up Birth Defects

The birth defect rate among women who used triptans during pregnancy was the same as for women who did not - 5 percent. The rate of major birth defects was 3 percent, which mirrors the rate of major birth defects among the general population.

However, women who used triptans during the second or third trimesters of their pregnancies were more likely to experience excessive bleeding after giving birth. This can be very dangerous and lead to death if doctors are unable to stop the bleeding.

These statistics were based on information provided to pregnancy registers that track information about women who use prescription drugs during their pregnancies. The researchers cautioned that while the results seem promising, independent confirmation of them is necessary.

The decision to take any medication while pregnant is a difficult one and should only be made after gathering information and discussing the issue candidly with your health care providers.

Technorati Tags: , , , ,


Subscribe to the Somebody Heal Me feed:
Subscribe in a reader or subscribe by e-mail.

Photo Sharing and Video Hosting at Photobucket Content by Diana E. Lee.

DISCLAIMER: Nothing on this site constitutes medical or legal advice. I am a patient who is engaged and educated and enjoys sharing my experiences and news about migraines, pain and depression. Please consult your own health care providers for advice on your unique situation.